Find Apimostinel manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1421866-48-9, Nrx-1074, Apimostinel [usan], Ttt1f11fzb, Apimostinel (usan), (2r)-1-[(2s)-1-[(2s,3r)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-2-benzylpyrrolidine-2-carboxamide
Molecular Formula
C25H37N5O6
Molecular Weight
503.6  g/mol
InChI Key
DVBUEXCIEIAXPM-PJUQSVSOSA-N
FDA UNII
TTT1F11FZB

Apimostinel
NRX-1074 has been used in trials studying the treatment of Schizophrenia.
1 2D Structure

Apimostinel

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R)-1-[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-2-benzylpyrrolidine-2-carboxamide
2.1.2 InChI
InChI=1S/C25H37N5O6/c1-15(31)19(26)23(35)29-12-6-10-18(29)22(34)30-13-7-11-25(30,14-17-8-4-3-5-9-17)24(36)28-20(16(2)32)21(27)33/h3-5,8-9,15-16,18-20,31-32H,6-7,10-14,26H2,1-2H3,(H2,27,33)(H,28,36)/t15-,16-,18+,19+,20+,25-/m1/s1
2.1.3 InChI Key
DVBUEXCIEIAXPM-PJUQSVSOSA-N
2.1.4 Canonical SMILES
CC(C(C(=O)N1CCCC1C(=O)N2CCCC2(CC3=CC=CC=C3)C(=O)NC(C(C)O)C(=O)N)N)O
2.1.5 Isomeric SMILES
C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@@]2(CC3=CC=CC=C3)C(=O)N[C@@H]([C@@H](C)O)C(=O)N)N)O
2.2 Other Identifiers
2.2.1 UNII
TTT1F11FZB
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1421866-48-9

2. Nrx-1074

3. Apimostinel [usan]

4. Ttt1f11fzb

5. Apimostinel (usan)

6. (2r)-1-[(2s)-1-[(2s,3r)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-2-benzylpyrrolidine-2-carboxamide

7. Threonyl-prolyl-2r-(2-benzyl)-prolyl-threonine Amide

8. L-threoninamide, L-threonyl-l-prolyl-2-(phenylmethyl)-l-prolyl-

9. Unii-ttt1f11fzb

10. Apimostinel [inn]

11. Apimostinel [who-dd]

12. Chembl3989872

13. Schembl14682282

14. Nrx1074

15. Dtxsid101031863

16. Agn-241660

17. Db11784

18. Hy-102053

19. Cs-0022853

20. D11299

21. Q27290341

22. L-threonyl-l-prolyl-2-benzyl-l-prolyl-l-threoninamide N-methyl-d-aspartate

2.4 Create Date
2013-03-21
3 Chemical and Physical Properties
Molecular Weight 503.6 g/mol
Molecular Formula C25H37N5O6
XLogP3-1
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count7
Rotatable Bond Count9
Exact Mass503.27438392 g/mol
Monoisotopic Mass503.27438392 g/mol
Topological Polar Surface Area179 Ų
Heavy Atom Count36
Formal Charge0
Complexity834
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty